Claritev Revenue 2019-2025 | CTEV

Claritev revenue from 2019 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Claritev Annual Revenue
(Millions of US $)
2024 $931
2023 $962
2022 $1,080
2021 $1,118
2020 $938
2019 $983
2018 $1,041
Claritev Quarterly Revenue
(Millions of US $)
2025-09-30 $246
2025-06-30 $242
2025-03-31 $231
2024-12-31 $232
2024-09-30 $230
2024-06-30 $233
2024-03-31 $235
2023-12-31 $244
2023-09-30 $243
2023-06-30 $238
2023-03-31 $237
2022-12-31 $241
2022-09-30 $250
2022-06-30 $290
2022-03-31 $298
2021-12-31 $298
2021-09-30 $288
2021-06-30 $276
2021-03-31 $255
2020-12-31 $255
2020-09-30 $224
2020-06-30 $207
2020-03-31 $252
2019-12-31
2018-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.528B $0.931B
Claritev Corporation is a healthcare technology, data and insights company. Claritev Corporation, formerly known as MultiPlan, is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.335B 44.34
Tempus AI (TEM) United States $12.322B 0.00
Doximity (DOCS) United States $8.258B 34.00
Hims & Hers Health (HIMS) United States $7.362B 59.89
IRhythm Technologies (IRTC) United States $5.445B 0.00
Hinge Health (HNGE) United States $3.816B 0.00
Privia Health (PRVA) United States $2.881B 180.15
Inspire Medical Systems (INSP) United States $2.816B 46.60
Heartflow (HTFL) United States $2.707B 0.00
10x Genomics (TXG) United States $2.506B 0.00
Omnicell (OMCL) United States $2.297B 46.96
Azenta (AZTA) United States $1.726B 70.83
Enovis (ENOV) United States $1.541B 8.09
Schrodinger (SDGR) United States $1.373B 0.00
Clover Health Investments (CLOV) United States $1.364B 0.00
Butterfly Network (BFLY) United States $1.079B 0.00
Phreesia (PHR) United States $1.033B 0.00
Fulgent Genetics (FLGT) United States $0.870B 0.00
Talkspace (TALK) United States $0.661B 133.00
Standard BioTools (LAB) United States $0.581B 0.00
Evolent Health (EVH) United States $0.463B 0.00
Zepp Health (ZEPP) Netherlands $0.387B 0.00
Carlsmed (CARL) United States $0.384B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.348B 0.00
TruBridge (TBRG) United States $0.328B 15.06
Senseonics Holdings (SENS) United States $0.291B 0.00
CapsoVision (CV) United States $0.281B 0.00
KORU Medical Systems (KRMD) United States $0.273B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.204B 0.00
Health Catalyst (HCAT) United States $0.174B 0.00
Nyxoah SA (NYXH) Belgium $0.173B 0.00
MDxHealth SA (MDXH) Belgium $0.162B 0.00
CareCloud (CCLD) United States $0.125B 6.84
Outset Medical (OM) United States $0.101B 0.00
EUDA Health Holdings (EUDA) Singapore $0.092B 0.00
HeartBeam (BEAT) United States $0.088B 0.00
Pulmonx (LUNG) United States $0.082B 0.00
American Well (AMWL) United States $0.081B 0.00
Retrieve Medical Holdings (RMHI) United States $0.068B 0.00
NetraMark Holdings (AINMF) Canada $0.067B 0.00
Precipio (PRPO) United States $0.046B 0.00
Evaxion - (EVAX) Denmark $0.043B 0.00
111 (YI) China $0.032B 0.00
Lunai Bioworks (LNAI) United States $0.022B 0.00
P3 Health Partners (PIII) United States $0.021B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
Zhongchao (ZCMD) China $0.014B 0.00
HeartSciences (HSCS) United States $0.010B 0.00
Bullfrog AI Holdings (BFRG) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
PROFUSA (PFSA) United States $0.008B 0.00
Movano (MOVE) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00